Seres Therapeutics Inc (MCRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 28,836 | 29,170 | 28,871 | 34,438 | 3,516 |
| Operating Income | -28,836 | -29,170 | -28,871 | -34,438 | -129,467 |
| Interest Expense | 0 | 0 | 0 | 618 | -2,667 |
| Other Income | 13,199 | -21,865 | 2,675 | 2,153 | 2,307 |
| Pre-tax Income | -15,637 | -51,035 | -26,196 | -32,903 | -124,493 |
| Net Income Continuous | -15,637 | -51,035 | -26,196 | -32,903 | -124,493 |
| Net Income Discontinuous | 0 | 139,811 | -6,674 | -7,230 | 83,245 |
| Net Income | $-15,637 | $88,776 | $-32,870 | $-40,133 | $-41,248 |
| EPS Basic Total Ops | -1.78 | 11.63 | -4.34 | -5.49 | -6.17 |
| EPS Basic Continuous Ops | -1.55 | -6.69 | -3.46 | -4.50 | -19.29 |
| EPS Basic Discontinuous Ops | -0.25 | 18.32 | -0.88 | -0.99 | 12.94 |
| EPS Diluted Total Ops | -1.78 | 11.63 | -4.34 | -5.49 | -6.17 |
| EPS Diluted Continuous Ops | -1.55 | -6.69 | -3.46 | -4.50 | -19.17 |
| EPS Diluted Discontinuous Ops | -0.25 | 18.32 | -0.88 | -0.99 | 12.94 |
| EPS Diluted Before Non-Recurring Items | N/A | -6.60 | -4.40 | N/A | N/A |
| EBITDA(a) | $-27,751 | $-27,303 | $-26,966 | $-32,414 | $-1,475 |